In addition, recombinant CT-1 treatment corrected insulin resistance and reduced adiposity in ob/ob and high-fat diet receiving mice, pointing to a key regulatory role of CT-1 in insulin sensitivity and lipid metabolism [6]. This evidence concerns the gene CTF1 and Insulin resistance.